- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03766828
Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion
May 27, 2019 updated by: Guerkan SENGOELGE, Medical University of Vienna
A unique inside-out-access technique with a new CE certified device (Surfacer (R) Bluegrass Vascular, San Antonio, Tx, USA) enables repetitive and confident right-sided placement of central venous catheters in hemodialysis patients with thoracic central venous occlusion.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
36
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vienna, Austria, 1180
- Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Hemodialysis patients with thoracic central venous occlusion requiring vascular access
Description
Inclusion Criteria:
- Patients with thoracic central venous occlusion
Exclusion Criteria:
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
inside-out-access technique with inside-out access device
|
inside-out-access technique with (Surfacer (R)) with a new CE certified device (Surfacer (R), Bluegrass Vascular)
|
|
access technique including Sharp recanalization
|
access technique with Sharp recanalization via interventional radiology
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Achievement of dialysis access
Time Frame: 1 day
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
procedure related complications
Time Frame: 3 months
|
infections, bleeding, hematoma or pericardial effusions and intervention related parameters
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gürkan Sengölge, Department of Medicine III, Division of Nephrology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2016
Primary Completion (Actual)
June 30, 2018
Study Completion (Actual)
June 30, 2018
Study Registration Dates
First Submitted
December 4, 2018
First Submitted That Met QC Criteria
December 4, 2018
First Posted (Actual)
December 6, 2018
Study Record Updates
Last Update Posted (Actual)
May 29, 2019
Last Update Submitted That Met QC Criteria
May 27, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Vienna-DialysisAccess
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Central Venous Catheter Thrombosis
-
Thomas KanderLund UniversityRecruitingCentral Venous Catheter | Coagulation | Coagulation Activation | Central Venous Catheter ComplicationsSweden
-
Fraser HealthSterileCare Inc.; Center for Health Evaluation & Outcome ServicesCompletedCentral Venous Catheter Thrombosis | Catheter Infection | Catheter Complications | Catheter | Catheter Blockage | Catheter Dysfunction | Central Line-associated Bloodstream Infection (CLABSI) | Central Venous Catheter Related Bloodstream InfectionCanada
-
Zhujiang HospitalUnknownCentral Venous Catheter Thrombosis | Catheter-Related Infections | Catheter Thrombosis | Central Venous Catheter Related Bloodstream InfectionChina
-
Policlinico HospitalCompletedCentral Venous Catheter Thrombosis | Intensive Care Unit | Thrombosis, Venous | Central Venous CathetersItaly
-
University of Texas Southwestern Medical CenterTerminatedDeep Vein Thrombosis | Childhood Cancer | Central Venous Catheters | Catheter-related Infection | Catheter-related OcclusionUnited States
-
Thomas KanderRecruitingCentral Venous Catheter ThrombosisSweden
-
Amsterdam UMC, location VUmcCompletedCentral Venous Catheter ThrombosisNetherlands
-
Second Affiliated Hospital, School of Medicine,...UnknownCentral Venous Catheter ThrombosisChina
-
London Health Sciences CentreCompletedCentral Venous Catheter Thrombosis | NeoplasmCanada
-
Chang Gung Memorial HospitalEnrolling by invitationCentral Venous Catheter Thrombosis | Renal DialysisTaiwan